Company intelligence / Profile preview

condenZero

Zurich, Zurich, Switzerland

Ownership: Private
Development stage: Other

Overview

condenZero develops and manufactures advanced cryogenic sample holders that enable atomic-scale research at ultra-low temperatures. Their flagship product allows researchers to perform experiments at 5K within one minute and maintain these conditions for up to 24 hours—significantly longer than competing solutions. The technology supports breakthroughs in quantum materials, nanotechnology, virology, protein structure analysis, and more.

Modalities: Device
Industry: Non-Drug Biotech

Partnerships

Forschungszentrum Jülich (pre-orders)Max Planck Institute Stuttgart (orders)

Beyond the preview

Go deeper on condenZero.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on condenZero.

Explore the full profile